Neoadjuvant immunotherapy in the evolving landscape of sarcoma treatment
Journal for ImmunoTherapy of Cancer · 2024
DOI: 10.1136/jitc-2024-010074 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Qiyan Cai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma and Sarcoma Medical Oncology Unit, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Sarcoma, Neoadjuvant Therapy, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Soft tissue sarcoma is characterized by its rarity and complexity, making it more difficult to conduct large clinical trials compared with other solid tumors. Also known as ‘cold tumors,’ sarcomas, especially advanced sarcomas, have poor responses to immunotherapy. Based on that, the results of two groundbreaking phase 2 clinical trials about neoadjuvant immunotherapy in patients with liposarcoma or undifferentiated pleomorphic sarcoma are encouraging. In this paper, we discuss the results of these clinical trials and the challenges we are facing to conduct neoadjuvant immunotherapy in sarcomas and call for further research to promote the development of it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Melanoma and Sarcoma Medical Oncology Unit, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
- Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
- Melanoma and Sarcoma Medical Oncology Unit, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China zhangxing@sysucc.org.cn.
ORCID-Profile: Xing Zhang
Zitieren
APA
Cai, Q., Que, Y., & Zhang, X. (2024). Neoadjuvant immunotherapy in the evolving landscape of sarcoma treatment. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-010074
Vancouver
Cai Q, Que Y, Zhang X. Neoadjuvant immunotherapy in the evolving landscape of sarcoma treatment. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2024-010074
BibTeX
@article{Cai2024,
author = {Cai, Qiyan and Que, Yi and Zhang, Xing},
title = {Neoadjuvant immunotherapy in the evolving landscape of sarcoma treatment},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
doi = {10.1136/jitc-2024-010074}
}
EUVIMED